Last reviewed · How we verify
Pexa-Vec combined with ZKAB001 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Pexa-Vec combined with ZKAB001 (Pexa-Vec combined with ZKAB001) — Lee's Pharmaceutical Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pexa-Vec combined with ZKAB001 TARGET | Pexa-Vec combined with ZKAB001 | Lee's Pharmaceutical Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pexa-Vec combined with ZKAB001 CI watch — RSS
- Pexa-Vec combined with ZKAB001 CI watch — Atom
- Pexa-Vec combined with ZKAB001 CI watch — JSON
- Pexa-Vec combined with ZKAB001 alone — RSS
Cite this brief
Drug Landscape (2026). Pexa-Vec combined with ZKAB001 — Competitive Intelligence Brief. https://druglandscape.com/ci/pexa-vec-combined-with-zkab001. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab